Tactical, Operational & Strategic Analysis of Markets, Competitors & Industries
The pharmaceutical and biotech market is changing. As product pipelines decrease, the threat of competition intensifies. Add to this the increase in generic and biosimilar entry and spiralling operation costs it’s easy to see that enough emphasis can not be placed on the importance of competitive intelligence (CI) to ensure the safety of current pipelines, increase market share and enhance company growth.
Following on the success of our 11th Competitive Intelligence in Pharma conference, which saw the largest European gathering of Competitive Intelligence professionals from the pharma and biotech industry, VIBpharma is proud to announce the 12th Annual Competitive Intelligence in Pharma conference will take place on 27-28 January 2009 in Madrid, Spain.
Extensive research at VIBpharma has ensured that that this conference programme accurately reflects the key priorities, challenges and desired solutions, as identified by experts from the pharmaceuticals industry.
Through a series of presentations and interactive discussions, covering issues such as anticipating brand erosion by generics, measuring the internal performance and ROI, integrating CI with other strategic functions, communicating CI to senior executives and creating a global intelligence network, participants will gain new insight and share hands-on experiences with leading companies in the pharma industry